Laporan Laba Rugi 002393 - TTM - Tianjin Lisheng Pharmaceutical Co.,Ltd.

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Tianjin Lisheng Pharmaceutical Co.,Ltd. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

	2020 09-30	2020 12-31	2021 03-31	2021 06-30	2021 09-30	2022 01-01	2022 03-31	2022 06-30	2022 09-30	2023 01-01	2023 03-31	2023 06-30	2023 09-30	2023 12-31	2024 03-31	2024 06-30	2024 09-30	2024 12-31	2025 03-31	2025 06-30
Revenue	1,321	1,141	1,136	1,114	1,061	1,092	1,071	1,119	1,158	1,147	1,176	1,189	1,156	1,153	1,182	1,240	1,265	1,336	1,341	1,323
Change (%)		-13.67	-0.44	-1.89	-4.78	2.91	-1.94	4.53	3.48	-1.01	2.54	1.16	-2.79	-0.27	2.54	4.90	2.02	5.61	0.37	-1.35
% of Revenue	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00

Cost Of Sales	467	456	478	480	468	474	460	471	491	511	519	518	497	488	529	566	594	624	607	593
Change (%)		-2.29	4.66	0.50	-2.64	1.37	-2.95	2.49	4.06	4.07	1.62	-0.22	-3.97	-1.83	8.32	7.02	4.96	5.11	-2.70	-2.32
% of Revenue	35.36	40.01	42.07	43.09	44.06	43.40	42.95	42.11	42.35	44.52	44.12	43.52	42.99	42.32	44.71	45.61	46.93	46.70	45.27	44.83

Gross Operating Profit	854	684	658	634	594	618	611	648	668	636	657	672	659	665	654	675	672	712	734	730
Change (%)		-19.89	-3.85	-3.63	-6.40	4.12	-1.16	6.08	3.06	-4.75	3.28	2.25	-1.89	0.91	-1.71	3.18	-0.44	6.04	3.07	-0.55
% of Revenue	64.64	59.99	57.93	56.91	55.94	56.60	57.05	57.89	57.65	55.48	55.88	56.48	57.01	57.68	55.29	54.39	53.07	53.30	54.73	55.17

SG&A	643	547	510	482	448	466	450	469	481	449	467	466	441	424	420	443	448	494	513	516
Change (%)		-14.83	-6.82	-5.57	-7.01	4.07	-3.44	4.10	2.63	-6.71	4.12	-0.29	-5.34	-3.77	-1.02	5.58	1.02	10.30	3.92	0.48
% of Revenue	48.64	47.99	44.91	43.23	42.22	42.69	42.04	41.87	41.52	39.13	39.73	39.17	38.14	36.80	35.53	35.76	35.41	36.98	38.29	39.00

R&D	82	73	78	93	94	101	101	107	111	102	100	103	91	102	103	91	119	122	128	129
Change (%)		-10.31	6.82	18.37	1.01	7.69	0.48	5.44	3.75	-7.71	-1.76	2.51	-11.74	12.74	0.64	-12.01	30.85	2.83	5.05	0.87
% of Revenue	6.18	6.43	6.89	8.32	8.82	9.23	9.46	9.54	9.57	8.92	8.54	8.66	7.86	8.89	8.72	7.32	9.38	9.14	9.56	9.78

OpEx	1,214	1,101	1,088	1,078	1,032	1,063	1,035	1,073	1,108	1,086	1,110	1,110	1,052	1,034	1,071	1,121	1,179	1,260	1,268	1,255
Change (%)		-9.32	-1.13	-0.91	-4.33	3.08	-2.67	3.65	3.28	-2.01	2.21	0.08	-5.23	-1.69	3.56	4.61	5.24	6.87	0.64	-1.06
% of Revenue	91.84	96.47	95.80	96.76	97.22	97.38	96.65	95.83	95.65	94.68	94.37	93.36	91.02	89.71	90.61	90.36	93.21	94.33	94.58	94.86

Operating Income	108	40	48	36	30	29	36	47	50	61	66	79	104	119	111	120	86	76	73	68
Change (%)		-62.62	18.29	-24.33	-18.12	-2.95	25.25	30.15	7.97	21.03	8.42	19.30	31.56	14.17	-6.41	7.70	-28.16	-11.82	-4.02	-6.49
% of Revenue	8.16	3.53	4.20	3.24	2.78	2.62	3.35	4.17	4.35	5.32	5.63	6.64	8.98	10.29	9.39	9.64	6.79	5.67	5.42	5.14

Interest Expense		-1	-0	-0	-0	-0	-0	-1	-1	-1	-1	-1	-1	-1	-2	-2	-2	-3	-2	-1
Change (%)			-45.35	-79.93	174.32	101.01	-3.79	101.93	1.83	38.04	6.52	-13.04	-3.60	-4.56	106.38	36.16	-5.52	34.10	-21.18	-55.55
% of Revenue		-0.05	-0.03	-0.01	-0.02	-0.03	-0.03	-0.06	-0.05	-0.08	-0.08	-0.07	-0.07	-0.06	-0.13	-0.17	-0.16	-0.20	-0.16	-0.07

Net Income	133	9	10	13	27	122	128	133	137	94	98	112	324	362	374	374	188	185	181	425
Change (%)		-93.50	20.92	27.68	104.22	349.53	4.83	3.75	3.17	-31.68	4.86	13.94	189.40	11.80	3.50	-0.13	-49.62	-2.06	-2.10	135.32
% of Revenue	10.03	0.76	0.92	1.19	2.56	11.18	11.95	11.86	11.83	8.16	8.35	9.40	27.99	31.38	31.67	30.16	14.89	13.81	13.47	32.13

Source: Capital IQ

Tianjin Lisheng Pharmaceutical Co.,Ltd. - Laporan Laba Rugi (TTM)

Laporan Laba Rugi (TTM)